Clinical trial
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00238914 |
|---|---|
| Title | Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 |
| Official title | Opiate Dependence: Combined Naltrexone/Behavior Therapy |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heroin Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | Naltrexone, Behavioral Naltrexone Therapy (BNT), Compliance Enhancement (CE) |
| Enrollment | 12 |
| Start date | Aug 1, 1999 |
| Primary completion | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Oct 14, 2005 |
| Last update posted | Jan 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: